Study on the Impact of Different Feeding Methods on Allergy Prevention and Digestive Absorption in Infants and Young Children
Condition(s) studied
Investigational drug(s) / intervention(s)
Observation: Collect questionnaire information.
biological sample collection: stool: Collect the stool sample from selected participants under standard instruction
Study summary
Based on a real-world research paradigm, this study aims to evaluate the performance of infants fed via different methods-specifically goat milk formula, control formula, and breastfeeding-regarding allergy prevention and protein digestion and absorption. The study begins with a cross-sectional survey to compare differences among these groups in terms of allergy-related markers, stool characteristics, and feeding difficulties. Subsequently, a prospective follow-up cohort study will be conducted based on these real-world feeding groups to monitor the incidence of allergies and other related data; stool samples will also be collected to analyze markers associated with protein digestion.
Eligibility
Primary outcome measure(s)
- Rates of infant allergy, respiratory disease, digestive disease occurrence in each group — Enrollment and 3 follow-up time points
Rates of disease using percentage(%) of affected population/ whole population in each group. - The Montreal Children's Hospital Feeding Scale, MCH-FS — Enrollment and 3 follow-up time points
The Montreal Children's Hospital Feeding Scale (MCH-Feeding Scale) consists of 14 items with each item scoring 1-7, the overall score range would be 14-98, higher score indicates poorer feeding performance. - 16s RNA gut microbiota — Enrollment and 3 follow-up time points
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Lanzhou Maternal and Child Health Hospital | Lanzhou | Gansu |
More Tsinghua University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07886437 on ClinicalTrials.gov ↗ ← All trials in China